Literature DB >> 22019809

Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemia.

Ki Won Moon1, Joonwan Kim, Jin Hyun Kim, Ran Song, Eun Young Lee, Yeong Wook Song, Eun Bong Lee.   

Abstract

OBJECTIVE: NSAIDs are commonly prescribed to control gout attacks in patients with hyperuricaemia. We investigated risk factors for NSAID-induced acute kidney injury (AKI) in patients with hyperuricaemia.
METHODS: We identified 328 patients with hyperuricaemia treated with NSAIDs at Seoul National University Hospital between December 1998 and January 2008 to investigate risk factors for NSAID-induced AKI. The risk factors evaluated included age, sex, BMI, comorbidity, NSAID COX-2 selectivity, baseline glomerular filtration rate (GFR), serum uric acid, serum albumin, haemoglobin level, ratio of blood urea nitrogen and serum creatinine and the use of allopurinol. After extracting possible risk factors through univariate analysis, multivariate logistic regression analysis was performed with backward selection to derive a risk model for NSAID-induced AKI in patients with hyperuricaemia.
RESULTS: Thirty (9.1%) NSAID users developed AKI. Univariate analysis revealed that old age (P = 0.008), low GFR (P = 0.001), low serum albumin (P < 0.001) and low haemoglobin levels (P < 0.001) were possible risk factors. Multivariate logistic regression analysis showed that low baseline GFR [odds ratio (OR) 4.86, 95% CI 1.27, 18.55, P = 0.021, for GFR 15-29 vs ≥60 ml/min/1.73 m(2)] and low serum albumin (OR 4.43, 95% CI 1.82, 10.80, P = 0.001, for albumin ≤4 vs >4 g/dl) are risk factors for NSAID-induced AKI in patients with hyperuricaemia.
CONCLUSION: Low GFR and low serum albumin are risk factors for AKI in hyperuricaemic patients treated with NSAIDs. Our results suggest that NSAIDs should be used with caution in patients with low serum albumin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019809     DOI: 10.1093/rheumatology/ker286

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

Review 1.  [DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain].

Authors:  W W Bolten; K Krüger; S Reiter-Niesert; D O Stichtenoth
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

Review 2.  Role of COX-2/mPGES-1/prostaglandin E2 cascade in kidney injury.

Authors:  Zhanjun Jia; Yue Zhang; Guixia Ding; Kristina Marie Heiney; Songming Huang; Aihua Zhang
Journal:  Mediators Inflamm       Date:  2015-02-01       Impact factor: 4.711

3.  COX-2/mPGES-1/PGE2 cascade activation mediates uric acid-induced mesangial cell proliferation.

Authors:  Shuzhen Li; Zhenzhen Sun; Yue Zhang; Yuan Ruan; Qiuxia Chen; Wei Gong; Jing Yu; Weiwei Xia; John Ci-Jiang He; Songming Huang; Aihua Zhang; Guixia Ding; Zhanjun Jia
Journal:  Oncotarget       Date:  2017-02-07

4.  Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort.

Authors:  Fernando Perez-Ruiz
Journal:  Rheumatol Ther       Date:  2017-09-27

Review 5.  Disease-Modifying Effects of Long-Term and Continuous Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Spondyloarthritis.

Authors:  Rebecca S Y Wong
Journal:  Adv Pharmacol Sci       Date:  2019-01-29

6.  An evaluation of gout visits in the United States for the years 2007 to 2011.

Authors:  Kristen E Castro; Kaitlyn D Corey; Diana L Raymond; Michael R Jiroutek; Melissa A Holland
Journal:  BMC Rheumatol       Date:  2018-05-30

Review 7.  Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury.

Authors:  Sheng Wang; Liyun Zhang; Dongsheng Hao; Lei Wang; Jiaxi Liu; Qing Niu; Liangyu Mi; Xinyue Peng; Jinfang Gao
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

8.  Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009.

Authors:  Eswar Krishnan; Linjun Chen
Journal:  Arthritis Res Ther       Date:  2013-11-06       Impact factor: 5.156

9.  Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study.

Authors:  Yu-Kang Chang; Jia-Sin Liu; Yueh-Han Hsu; Der-Cherng Tarng; Chih-Cheng Hsu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.